Read more on CorMedix (CRMD)'s FDA-approved DefenCath and its potential in the CRBSI market, but be cautious of stock spikes ...

Glioblastoma is the most common and lethal form of brain cancer in adults with a universally fatal prognosis, particularly when it recurs. The median survival post-recurrence is 6.5 months, making any ...

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on third-quarter financial results and a surgical ...

The majority of the 390 hospitals surveyed (79.2%) were understaffed according to the calculator in infection control ...

AVI’s FDA-cleared devices have been shown to lower complication rates by a factor of six, compared with standard catheters, and an in vitro study demonstrated a 99.99% reduction in bacterial adhesion.

If you’re in the market for a new car, it’s important to understand what engine size means and how it affects a car’s performance and economy. Engine size, also referred to as ‘engine ...

Other published studies have shown that AVI’s FDA-cleared devices, crafted from the MIMIX® biomaterial that emulates the natural chemistry of the human body, demonstrated a sixfold reduction in ...

demonstrated a sixfold reduction in complications compared to standard catheters, while in vitro data showed a 99.99% reduction in bacterial adhesion. 1,2 “Making the decision to change clinical ...

demonstrated a sixfold reduction in complications compared to standard catheters, while in vitro data showed a 99.99% reduction in bacterial adhesion. 1,2 About Access Vascular Access Vascular was ...